Curegenix, Inc.
Records under this name other than the patents Curegenix, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 2 of 2 · Back to Curegenix, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,087,181 | Compound as WNT Signaling Inhibitor, Composition, and Use Thereof Lapsed on the fee record Ended Oct 2, 2026 · Medium confidence | Lapsed on the fee record | Ended Oct 2, 2026 | Medium confidence |
| US 8,785,442 | Compound as Antagonist of Lysophosphatidic Acid Receptor, Composition, and Use Thereof Lapsed on the fee record Ended Jul 22, 2026 · High confidence | Lapsed on the fee record | Ended Jul 22, 2026 | High confidence |